期刊文献+

3种喹诺酮类药三联方对幽门螺杆菌体外抗菌效果与临床根除率观察 被引量:2

In Vitro Antibiotic Effects of 3 Quinolone Triple Therapy Against Helicobacter Pylori and Eradication Rate
下载PDF
导出
摘要 目的评价3种喹诺酮类药与阿莫西林对180株幽门螺杆菌(Hp)体外联合抗菌效应和临床根除率。方法采用二倍稀释法和棋盘格法,测定3种喹诺酮类药(环丙沙星、左氧氟沙星、莫西沙星)分别与阿莫西林单用及联用对180株Hp的最低抑菌浓度(MIC),计算其联合药敏指数(FIC值),并观察3种喹诺酮类药与奥美拉唑三联方根除Hp感染的疗效。结果3种喹诺酮类药与阿莫西林联用对Hp致病菌的MIC值均显著降低。环丙沙星FIC值:0.5~1为相加作用;左氧氟沙星FIC值0.5~0.75为相加作用,莫两沙星FIC值;0.09375~0.1875为协同作用。3种喹诺酮类药与奥美拉唑的三联方对Hp临床根除率分别为91.67%、73.33%和60.00%,P〈0.05。结论3种喹诺酮类药与阿莫西林联用对180株Hp抗菌作用增强以协同作用和相加作用为主,无拮抗效应,其Hp根除率排序莫西沙星〉左氧氟沙星〉环丙沙星。 Objective To valuate the antibiotic effects in vitro of 3 quinolones combined with Amoxillin against 180 Helieobacter pylori(Hp) strains and study the Hp eradication rate in our clinic. Methods With the method of agar dilution test and checkboard test, The MIC of ciprofloxacin and Amoxillin, Levofloxacin and Amoxillin, Moxifloxacin and Amoxillin alone or in combination against 180 strains Hp were detected and FIC index was calculated according to MIC values. The curative effect of 3 quinolones and omeprazole tripl therapy on eradication of Hp infection was observed. Results The MIC of 3 quinolones combined with Amoxillin against Hp was reduced significantly. FIC index of ciprofloxacin of 0.5 - 1.0 was additive action. FIC index of Levofloxacin of 0.5 - 0.75 was additive action. FIC index of Moxifloxacin of 0. 09375 - 0.1875 was synergism action. The Hp eradication rate of 3 quinalones and Omeprazole tripl therapy in our clinic was 91.67% ,73.33% and 60.00% , respectively ( P 〈 0.05). Conclusion The antibiotic activity of 3 quinolones combined with Amoxillin against 1 80 Hp strains was enhanced significantly. Their effect was characterized by synergism and additive action instead of antagonistic effect. The Hp eradication rate was Moxifloxacin 〉 levofloxacin 〉 Ciprofioxacin.
出处 《医学研究杂志》 2010年第3期111-113,共3页 Journal of Medical Research
关键词 喹诺酮类药 阿莫西林 奥美拉唑 联合用药 三联方:幽门螺杆菌根除率 Quinolone Amoxillin Omeprazole Coadministration Triple therapy : Eradication of helicobacter pylori(Hp)
  • 相关文献

参考文献9

二级参考文献46

共引文献235

同被引文献31

  • 1靳宝兰.氟喹诺酮类药物临床应用进展[J].继续医学教育,2004,18(4):46-48. 被引量:2
  • 2刘明亮.非氟喹诺酮的发现、构-效关系及其特性[J].国外医药(抗生素分册),2006,27(1):16-21. 被引量:4
  • 3百时美施贵宝公司决定从市场撤出加替沙星[J].中国药物警戒,2006,3(4):251-252. 被引量:8
  • 4成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 5Sekiguchi H, Takabayashi F, Deguchi Y, et al. Leaf ex- tract of wasabia japonica relieved oxidative stress induced by helieobacter pylori infection and stress loading in mon- golian gerbils[J]. Biosci Biotechnol Biochem, 2010, 74 (6) : 1 194. 被引量:1
  • 6Basu PP, Rayapudi K, Pacana T, et al. A randomized st- udy comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori[J]. Am J Gastroenterol, 2011, 106 (11):1 970. 被引量:1
  • 7Cuadrado-Lavin A, Salcines-Caviedes JR, Carrascosa MF, et al. Levofloxacin versus clarithromycin in a 10 day tri- ple therapy regimen for first-line helicobacter pylori eradi- cation: A single-blind randomized clinical trial[J]. J Anti- microb Chemother,2012,67(9) :2 254. 被引量:1
  • 8Roubaud Baudron C, Letenneur L, Langlais A, et al.Do- es helicobacter pylori infection increase incidence of de- mentia? the personnes Ag6es QUID study[J]. J Am Geri- atrSoc, 2013 ,61(1):74. 被引量:1
  • 9Perry S, Chang AH, Sanchez L, et al. The immune resp- onse to tuberculosis infection in the setting of helicobacter pylori and helminth infections[J]. Epidemiollnfect, 2013, 141(6):1 232. 被引量:1
  • 10Nakamura S, Yanagihara K, Araki N, et al. Efficacy of zlarithromycin against experimentally induced pneumonia zaused by clarithromycin-resistant Haemophilus influen- ae in mice[J]. Antimierob Agents Chemother, 20[0, 54 (2):757. 被引量:1

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部